Clinical trial / 2024
Vitamin B12 supplementation for one month did not significantly reduce tinnitus severity compared to placebo.
A double-blind clinical trial evaluated the effect of vitamin B12 supplementation versus placebo for one month in 140 patients with idiopathic tinnitus. There were no statistically significant differences in tinnitus severity based on VAS scores between groups at baseline (p = 0.560), one month (p = 0.485), or three months (p = 0.254). Similarly, THI scores showed no significant differences between groups at baseline (p = 0.651), one month (p = 0.125), or three months (p = 0.089), nor by hearing loss status. No noticeable side effects were observed in either group.
- Study type
- Double-blind randomized controlled trial
- Who was studied
- 140 patients with idiopathic tinnitus
- What was measured
- Tinnitus severity via THI and VAS scores, hearing loss status, side effects
THE PAPER
The effect of vitamin B12 on idiopathic tinnitus.
Dadgarnia M, Mandegari M, Zand V, Vaziribozorg S, Zare-Zardini H, Mousaviyazdi K, Kheradmandi M. Am J Otolaryngol, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.